Federal award
INHALON BIOPHARMA, INC.
HT942525CE039
ContractSBIR/STTR SR3
Obligated and Ceiling
- Obligated (net)
- $3,175,643.00
- Ceiling (potential value, not spending)
- $3,175,643.00
- Current value
- $3,175,643.00
- Gross positive obligations
- $3,175,643.00
Obligated is what the government has committed, net of de-obligations. The ceiling is the most the award or vehicle could ever reach; it is shown separately and never added to, or compared as, spending.
Award Details
- Recipient
- INHALON BIOPHARMA, INC. · HFQSJ2GMNRU6
- Owner company
- Not a reviewed companyNo reviewed company owns this recipient.
- Reported parent
- INHALON BIOPHARMA, INC. · HFQSJ2GMNRU6
- Awarding agency
- Department of War · sub-agency 97DH · office HT9425
- Funding agency
- Department of War · sub-agency 97DH
- Product or service (PSC)
- AN13 · HEALTH R&D SERVICES; HEALTH CARE SERVICES; EXPERIMENTAL DEVELOPMENT
- Industry (NAICS)
- 541715 · RESEARCH AND DEVELOPMENT IN THE PHYSICAL, ENGINEERING, AND LIFE SCIENCES (EXCEPT NANOTECHNOLOGY AND BIOTECHNOLOGY)
- PIID
- HT942525CE039
- Award type code
- D
- Actions
- 1 · Sep 22, 2025 to Sep 22, 2025
- Why it is listed
- gross positive obligations of $100k or more (contracts); SBIR/STTR award
Action History1
| Date | FY | Mod | Action type | Obligation | Company in company totals |
|---|---|---|---|---|---|
| Sep 22, 2025 | FY2025 | 0 | — | $3,175,643.00 | — |
Newest first. Every obligation is shown as reported, including zero and negative (de-obligation) actions. Award lists belong to the company of the latest action; company totals credit each action to the company named on that row, so a note marks rows where the two differ.